These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3603256)

  • 21. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children.
    Schaad UB; Suter S; Gianella-Borradori A; Pfenninger J; Auckenthaler R; Bernath O; Cheseaux JJ; Wedgwood J
    N Engl J Med; 1990 Jan; 322(3):141-7. PubMed ID: 2403654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and pharmacokinetic study of ceftriaxone in the treatment of 14 episodes of ascitic fluid infection].
    Ducroix JP; Guerlin M; Hary L; Smail A; Denamur E; Eb F; Andrejak M; Baillet J
    Pathol Biol (Paris); 1988 Oct; 36(8):1007-10. PubMed ID: 3059283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ceftriaxone versus cefuroxime for meningitis in children.
    Wrenn K
    N Engl J Med; 1990 Jun; 322(25):1821. PubMed ID: 2345571
    [No Abstract]   [Full Text] [Related]  

  • 24. Ceftriaxone in the treatment of meningitis, gonococcal infections and other serious bacterial infections. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1990 Mar; 142(5):450-2. PubMed ID: 2302641
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical evaluation of ceftriaxone in severe infections in adults].
    Lacut JY; Dupon M; Quentin C; Brachet-Liermain A; Granger C; Echinard E
    Pathol Biol (Paris); 1986 May; 34(5):451-6. PubMed ID: 3534720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics of ceftriaxone in the first three month of life].
    Rondanelli R; Regazzi MB; Stronati M; Calvi M; Lombardi G; Rondini G
    Pediatr Med Chir; 1992; 14(1):55-9. PubMed ID: 1579518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inappropriate ceftriaxone use in the emergency department of a tertiary hospital in Melbourne, Australia.
    Xie C; Charles PG; Urbancic K
    Emerg Med Australas; 2013 Feb; 25(1):94-6. PubMed ID: 23379463
    [No Abstract]   [Full Text] [Related]  

  • 28. Ceftriaxone: increasing the half-life and activity of third generation cephalosporins.
    Steele RW
    Pediatr Infect Dis; 1985; 4(2):188-91. PubMed ID: 3885182
    [No Abstract]   [Full Text] [Related]  

  • 29. Ceftriaxone is twice as cost-effective as standard therapy in biliary tract infection.
    Zoepf T; Jakobs R; Riemann JF
    Hepatogastroenterology; 2004; 51(58):941-5. PubMed ID: 15239219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study with ceftriaxone (Rocephin) versus ampicillin and chloramphenicol in children with bacterial meningitis.
    Ngu J; Youmbissi T
    Chemioterapia; 1987 Jun; 6(2 Suppl):417-8. PubMed ID: 3334588
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparison of ceftriaxone (1 g single dose) versus cefotaxime (three 1 g doses) for gynecologic and obstetric infections.
    Gerstner GJ
    J Chemother; 1989 Jul; 1(4 Suppl):884-6. PubMed ID: 16312686
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of neurosurgical bacterial meningitis using the combination of ceftriaxone-fosfomycin].
    Stahl JP; Croize J; Baud A; Bru JP; de Rougemont P; Le Noc P; Micoud M
    Pathol Biol (Paris); 1986 May; 34(5):479-82. PubMed ID: 3534726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bacterial colonization and antibiotic therapy of mal perforant].
    Hirschl M; Hirschl AM
    Vasa Suppl; 1991; 33():165. PubMed ID: 1788658
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of a rational and consensual protocol for the use of ceftriaxone in a general hospital].
    Gómez Vargas J; Gómez J; Ruiz Gómez J; Simarro E; San Miguel T; Canteras M; Valdés M
    Rev Esp Quimioter; 1998 Dec; 11(4):327-32. PubMed ID: 9990146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost considerations in the treatment of paediatric infections.
    Steele RW
    S Afr Med J; 1987 Jun; Suppl 2():7-9. PubMed ID: 3603258
    [No Abstract]   [Full Text] [Related]  

  • 36. Once-daily administration of ceftriaxone for the treatment of selected serious bacterial infections in children.
    Frenkel LD
    Pediatrics; 1988 Sep; 82(3 Pt 2):486-91. PubMed ID: 3405685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftriaxone drug utilization evaluation in a large community hospital.
    Sesin GP; Gannon PM
    DICP; 1991; 25(7-8):872-3. PubMed ID: 1949954
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of anti-bacterial immuno-ribonucleic acid in the treatment of burns complicated with systemic infection].
    Zhang GD
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1987 Sep; 3(3):198-9. PubMed ID: 2477127
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of extensive infected burns].
    AGOPIAN K
    Rev Med Moyen Orient; 1951; 8(3):325-39. PubMed ID: 14876177
    [No Abstract]   [Full Text] [Related]  

  • 40. Reply to Elamin et al.
    Lachiewicz AM; van Duin D
    Clin Infect Dis; 2018 Aug; 67(6):982-983. PubMed ID: 29741612
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.